<?xml version="1.0" encoding="UTF-8"?>
<p>The first stage of vaccine development is research intensive and involves the identification of natural or synthetic antigens based on the viral protein. Within a week of sequencing the SARS-CoV-2 genome, Chinese scientists had shared this publicly.
 <sup>
  <xref rid="bibr2-1470320320926902" ref-type="bibr">2</xref>,
  <xref rid="bibr3-1470320320926902" ref-type="bibr">3</xref>
 </sup> Sharing the viral genome globally has allowed for an acceleration of the early development stage. Researchers at Imperial College London, for example, took just two weeks from receiving the genome to producing a candidate vaccine.
 <sup>
  <xref rid="bibr4-1470320320926902" ref-type="bibr">4</xref>
 </sup>
</p>
